Inhibikase Therapeutics holds R&D Day; presentation content not fully available in filing

Inhibikase Therapeutics, Inc.

Company presented to investors at R&D Day on March 22, 2023.
The 8-K includes presentation as Exhibit 99.1 but only title slide and disclaimer are visible in the filing excerpt.
No specific pipeline data, financial figures, or clinical milestones are extractable from the provided text.
Investors should consult the full presentation on the company's website or other SEC filings for details.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.